SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VPHM - Viropharma Inc
An SI Board Since December 1998
Posts SubjectMarks Bans Symbol
2557 72 0 VPHM
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1032Could merely be that, other than BTRN, there is no more likely biotech candidatekeokalani'nui-11/25/2002
1031I am absolutely fascinated with trading in this issue. Does it seem very strangscaram(o)uche-11/25/2002
1030Not enough NCEs and innovation....... Message 18245875scaram(o)uche-11/18/2002
1029I went back and listened to the conference call again. The company remains commscaram(o)uche-11/10/2002
1028aasld abstracts, off of embargo...... Publishing ID: 800 Abstractid ID: 101544 scaram(o)uche-11/6/2002
1027AASLD presentation re. BILN 2061 (pointer from sivirusdude at Yahoo thread).....scaram(o)uche-11/6/2002
1026Message 18173905scaram(o)uche-10/31/2002
1025irconnect.com did you listen to them ???farkarooski-10/31/2002
1024not enough. :-) too many. :-(scaram(o)uche-10/31/2002
1023<<it seems as though there are 25B shares out, not 25M.>> how many farkarooski-10/31/2002
1022103K share block after the close. ya know, it seems as though there are 25B shascaram(o)uche-10/31/2002
1021Thanks. Sounds upbeat -- or maybe I am wishful...(eom)mopgcw-10/30/2002
1020No member of R&D in on the conference call, just de Rosen, Milano and Kori Bscaram(o)uche-10/30/2002
1019<i>In addition, during the third quarter of 2002 the company purchased $23scaram(o)uche-10/29/2002
1018We end up with 22M in shareholder equity. Cash and equivalents $176M, 24.7M shascaram(o)uche-10/29/2002
1017<i>In addition, during the third quarter of 2002 the company purchased $23scaram(o)uche-10/29/2002
1016we get info today re. whether or not they've bought back debt. we will probscaram(o)uche-10/29/2002
1015Short interest drops again (down another 220K to 2.4M), days to cover (30) remaiscaram(o)uche-10/26/2002
1014continues to improve, IMO...... www-micro.msb.leicester.ac.uk I'm no experscaram(o)uche-10/20/2002
1013>> It is a nice hope. << And a very leveraged hope. Let's hopescaram(o)uche-10/14/2002
1012"Review the anecdote for pleconaril at PubMed. I have no doubt that the molCacaito-10/14/2002
1011DARPA, NIST, NIH/SBIR grants...... companies are rolling in available cash. whscaram(o)uche-10/8/2002
1010<i> His mistake was taking the job in the first place...</i> Francenigel bates-9/30/2002
1009It hurts to laugh. Stop that. His mistake was taking the job in the first placscaram(o)uche-9/30/2002
1008Is the person that recommended the appointment the same one that put Greenspan unigel bates-9/30/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News